Study objective: To evaluate the effectiveness of the Gynecare Morcellex tissue morcellator (Ethicon, Inc., Somerville, NJ) in laparoscopic supracervical hysterectomy and myomectomy.
Design: Randomized controlled trial (Evidence I).
Setting: University department of obstetrics and gynecology.
Patients: Seventy-four patients with symptomatic uterine myomas scheduled for laparoscopic supracervical hysterectomy or myomectomy.
Interventions: Laparoscopic supracervical hysterectomy and myomectomy followed by tissue morcellation using the Gynecare Morcellex (experimental group) or the Rotocut G1 morcellator (Karl Storz GmbH & Co. KG, Tuttlingen, Germany) (control group).
Measurements and main results: Patient characteristics and surgical data were noted for both groups. No difference was detected between groups in any parameters assessed, whereas a significant difference (p <.05) in handling score was detected in the experimental group compared with the control group.
Conclusion: The Gynecare Morcellex is an effective instrument with excellent safety and handling.
Copyright 2010 AAGL. Published by Elsevier Inc. All rights reserved.